Working with Ex Vivo Organ Perfusion to help manage inflammatory processes
*Not available in the US
The ECOS-300CY® sorbent cartridge is the first product designated and approved by under EU regulations explicitely to help removing specific cytokines and other inflammatory mediators during Ex Vivo Organ Perfusion (EVOP).
EVOP is a recently established technique in solid-organ transplantation in which harvested organs — such as the heart, lungs, liver, or kidneys — are perfused with oxygenated, temperature-controlled blood or perfusate outside the body.
The ECOS-300CY® Therapy System is a CE-marked device specifically approved in the EU for the removal of cytokines and other inflammatory mediators during ex vivo organ perfusion.
Additional Information
- Hosgood SA et al., J Transl Med. 2017; 15(1):216
- Iskender I et al., JTCVS. 2021; 161(2):e109-e121
- Lindstedt S et al., J Heart Lung Transplant. 2023; 42(10):1358-1362
- Boffini M et al., Transplant Int. 2023; 36:10777
- Niromand A et al., Front Cardiovasc Med. 2023; 10:127444
Contact us to learn more about ECOS – 300CY Therapy
Get in touch
CytoSorbents
Voices around the world